- Life Sciences
- Conference
World CB & CDx Summit 2025
Tempus is advancing precision medicine through the practical application of artificial intelligence in healthcare. We are pleased to attend the 15th World Clinical Biomarkers & Companion Diagnostics Summit and present how Tempus can support strategic CDx development through to commercialization.
Reshaping Diagnostic Development: A Research-First Approach to Market Access
Reframe the traditional, siloed approach to CDx development and discover how the Tempus platform provides a more unified solution. Learn how you can leverage our multimodal, real-world data-powered research engine to inform trial design, execute studies more efficiently, and build a strong foundation for your commercial goals. See how our research-first model is designed to generate robust, submission-ready evidence, helping you to navigate the regulatory landscape and accelerate the path to approval for your companion diagnostics. Add to calendar
Lauren Silvis, Senior Vice President of External Affairs (Tempus); Mike Yasiejko, Executive Vice President and General Manager, Genomics (Tempus)
Schedule a meeting with us
We'll be in touch shortly.